Pharmaceutical News

RSS

Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease

One in five people with Alzheimer's disease who use a benzodiazepine are also concomitant users of an opioid, according to a new study from the University of Eastern Finland.

19 Nov 2018

Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia

Nightmares and insomnia often accompany posttraumatic stress disorder and increase suicide risk.

19 Nov 2018

Recreational drug may help people regain trust in others

The recreational drug known as ecstasy or molly may help people regain trust in others after being betrayed, suggests results of a controlled laboratory study, published in JNeurosci, of healthy men given a pure form of the substance.

From Society for Neuroscience 19 Nov 2018

Cardiff University collaborates with Takeda to identify new treatment approaches for psychiatric disorders

Cardiff University has formed a drug discovery collaboration with Takeda to identify new approaches for treating schizophrenia and other psychiatric disorders.

From Takeda 19 Nov 2018

Researchers identify molecule to fight myotubular myopathy

Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva, Switzerland, - working in collaboration with the University of Strasbourg, France, - have identified a molecule that not only greatly reduces the progression of the disease but also boosts life expectancy in animal models by a factor of seven.

19 Nov 2018

Insilico Medicine to introduce 'Cure a disease in a year' program at Biodata World Congress 2018

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery and real world evidence pipeline utilizing the next generation artificial intelligence, will present its research and introduce the "Cure a disease in a year" program at the World's leading congress for big data in precision medicine - Biodata World Congress 2018.

19 Nov 2018

Parents who decline flu vaccination for their child may be exposed to limited information

Parents who decline to get their child vaccinated against the flu may be exposed to a limited range of information, a new national poll suggests.

19 Nov 2018

Individuals identified as lesbian, gay more likely to misuse opioids than heterosexual

Men and women who identify as lesbian, gay, or bisexual are more likely to misuse opioids when compared with those who identify as heterosexual, a new study shows.

19 Nov 2018

Surprising discovery about BH4 may rekindle interest in once-promising pathway

In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, PhD, and chemist Kai Johnsson, PhD, his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief.

19 Nov 2018

Human drugs alter cricket personality

Crickets that are exposed to human drugs that alter serotonin levels in the brain are less active and less aggressive than crickets that have had no drug exposure, according to a new study led by researchers from Linköping University. The findings have been published in Scientific Reports.

18 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.

16 Nov 2018

Drug used to treat dizziness may slow down growth of triple-negative breast cancer

Screening Food and Drug Administration approved compounds for their ability to stop cancer growth in the lab led to the finding that the drug flunarizine can slow down the growth of triple-negative breast cancer in an animal model of the disease.

16 Nov 2018

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals' Arsenic Trioxide Injection is available as 10 mg per 10 mL vial for injection.

16 Nov 2018

New pharmacological agent shows promise for prevention of heart rhythm disorders

A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias.

15 Nov 2018

RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders

RetiPharma has secured funding from the Novo Nordisk Foundation’s BioInnovation Institute to develop a new drug for degenerative eye disorders.

From Novo Nordisk 15 Nov 2018

Mylan and Biocon launch new insulin glargine biosimilar in the UK

Mylan N.V. and Biocon Ltd. today announced the UK launch of Semglee (Insulin Glargine solution for injection in pre-filled pen) 100 units/mL, an approved biosimilar of reference insulin glargine.

From Viatris Inc. 15 Nov 2018

Scientists try to develop portable systems that can quickly produce biologics on demand

Many life-saving medicines, including insulin, antibodies and vaccines, are derived from living cells. These "biologics" can be difficult to obtain and store on the battlefield or in remote areas.

15 Nov 2018

FDA warns against use of unapproved pain medications with implanted pumps

The U.S. Food and Drug Administration today alerted health care providers and patients about the serious complications that can occur when using medications not approved for use with implanted pumps that deliver medication into the spinal fluid to treat or manage pain.

15 Nov 2018

Pharmaceutical News

Concomitant use of sleeping pills and opioids found to prevalent among people with Alzheimer’s disease

Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia

Recreational drug may help people regain trust in others

Cardiff University collaborates with Takeda to identify new treatment approaches for psychiatric disorders

Researchers identify molecule to fight myotubular myopathy

Insilico Medicine to introduce 'Cure a disease in a year' program at Biodata World Congress 2018

Parents who decline flu vaccination for their child may be exposed to limited information

Individuals identified as lesbian, gay more likely to misuse opioids than heterosexual

Surprising discovery about BH4 may rekindle interest in once-promising pathway

Human drugs alter cricket personality

FDA approves antibacterial drug to treat travelers' diarrhea

New first-line treatment for peripheral T-cell lymphoma approved by FDA

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

Drug used to treat dizziness may slow down growth of triple-negative breast cancer

Nexus announces availability of Arsenic Trioxide Injection in the US

New pharmacological agent shows promise for prevention of heart rhythm disorders

RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders

Mylan and Biocon launch new insulin glargine biosimilar in the UK

Scientists try to develop portable systems that can quickly produce biologics on demand

FDA warns against use of unapproved pain medications with implanted pumps

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

Latest News